Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' HERAIT P' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 19 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Freyer, G; Rougier, P; Bugat, R; Droz, JP; Marty, M; Bleiberg, H; Mignard, D; Awad, L; Herait, P; Culine, S; Trillet-Lenoir, V
      Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure

      BRITISH JOURNAL OF CANCER
    2. Van Cutsem, E; Cunningham, D; Huinink, WWT; Punt, CJA; Alexopoulos, CG; Dirix, L; Symann, M; Blijham, GH; Cholet, P; Fillet, G; Van Groeningen, C; Vannetzel, JM; Levi, F; Panagos, G; Unger, C; Wils, J; Cote, C; Blanc, C; Herait, P; Bleiberg, H
      Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU)

      EUROPEAN JOURNAL OF CANCER
    3. WASSERMAN E; MYARA A; LOKIEC F; RIOFRIO M; IMADALOU K; BLEUZEN P; SANTONI J; TRIVIN F; HERAIT P; MAHJOUBI M; ARMAND JP; MISSET JL; CVITKOVIC E
      BILIRUBIN (BIL) AND SN-38 - PHARMACOKINETIC PHARMACODYNAMICS CORRELATION/

      Annals of oncology
    4. SALIBA F; HAGIPANTELLI R; MISSET JL; BASTIAN G; VASSAL G; BONNAY M; HERAIT P; COTE C; MAHJOUBI M; MIGNARD D; CVITKOVIC E
      PATHOPHYSIOLOGY AND THERAPY OF IRINOTECAN-INDUCED DELAYED-ONSET DIARRHEA IN PATIENTS WITH ADVANCED COLORECTAL-CANCER - A PROSPECTIVE ASSESSMENT

      Journal of clinical oncology
    5. ROUGIER P; VANCUTSEM E; BAJETTA E; NIEDERLE N; POSSINGER K; LABIANCA R; NAVARRO M; MORANT R; BLEIBERG H; WILS J; AWAD L; HERAIT P; JACQUES C
      RANDOMIZED TRIAL OF IRINOTECAN VERSUS FLUOROURACIL BY CONTINUOUS-INFUSION AFTER FLUOROURACIL FAILURE IN PATIENTS WITH METASTATIC COLORECTAL-CANCER

      Lancet
    6. CUNNINGHAM D; PYRHONEN S; JAMES RD; PUNT CJA; HICKISH TF; HEIKKILA R; JOHANNESEN TB; STARKHAMMAR H; TOPHAM CA; AWAD L; JACQUES C; HERAIT P
      RANDOMIZED TRIAL OF IRINOTECAN PLUS SUPPORTIVE CARE VERSUS SUPPORTIVECARE ALONE AFTER FLUOROURACIL FAILURE FOR PATIENTS WITH METASTATIC COLORECTAL-CANCER

      Lancet
    7. BLIJHAM G; SCHMITT C; AUSSAGE P; HENRYLAUNOIS B; JOLAIN B; HERAIT P
      COST-EFFECTIVENESS OF IRINOTECAN (CPT-11) AND BEST ESTIMATED CHEMOTHERAPY REGIMEN IN PATIENTS WITH METASTATIC COLORECTAL-CANCER AFTER FAILURE OF 5FLUOROURACIL (5FU) CONTAINING REGIMEN - RESULTS BASED ON A PHASE-III TRIAL

      European journal of cancer
    8. WASSERMAN E; MYARA A; RIOFRIO M; PAUMIER D; HERAIT P; AWAD L; MISSET JL; CVITKOVIC E
      BILIRUBIN - BASE-LINE VALUE AND TRANSIENT INCREASE OF TOTAL BILIRUBIN(BIL) MAY BE USED AS GOOD PREDICTOR OF CPT-11S TOXICITY

      European journal of cancer
    9. SASTRE J; PAZARES L; DIAZRUBIO E; CORTESFUNES H; CARCAS A; GRUIA G; HERAIT P; FDZCHACON C; MARTIN C; FARR I
      PHASE-I DOSE-FINDING STUDY OF IRINOTECAN (CPT-11) OVER A SHORT IV INFUSION COMBINED WITH A FIXED-DOSE OF 5-FLUOROURACIL (5-FU) PROTRACTED CONTINUOUS IV INFUSION IN PATIENTS WITH ADVANCED SOLID TUMORS

      European journal of cancer
    10. MERROUCHE Y; EXTRA JM; ABIGERGES D; BUGAT R; CATIMEL G; SUC E; MARTY M; HERAIT P; MAHJOUBI M; ARMAND JP
      HIGH DOSE-INTENSITY OF IRINOTECAN ADMINISTERED EVERY 3 WEEKS IN ADVANCED CANCER-PATIENTS - A FEASIBILITY STUDY

      Journal of clinical oncology
    11. ROUGIER P; BUGAT R; DOUILLARD JY; CULINE S; SUC E; BRUNET P; BECOUARN Y; YCHOU M; MARTY M; EXTRA JM; BONNETERRE J; ADENIS A; SEITZ JF; GANEM G; NAMER M; CONROY T; NEGRIER S; MERROUCHE Y; BURKI F; MOUSSEAU M; HERAIT P; MAHJOUBI M
      PHASE-II STUDY OF IRINOTECAN IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER IN CHEMOTHERAPY-NAIVE PATIENTS AND PATIENTS PRETREATED WITH FLUOROURACIL-BASED CHEMOTHERAPY

      Journal of clinical oncology
    12. CANAL P; GAY C; DEZEUZE A; DOUILLARD JY; BUGAT R; BRUNET R; ADENIS A; HERAIT P; LOKIEC F; MATHIEUBOUE A
      PHARMACOKINETICS AND PHARMACODYNAMICS OF IRINOTECAN DURING A PHASE-IICLINICAL-TRIAL IN COLORECTAL-CANCER

      Journal of clinical oncology
    13. ARMAND JP; DUCREUX M; MAHJOUBI M; ABIGERGES D; BUGAT R; CHABOT G; HERAIT P; DEFORNI M; ROUGIER P
      CPT-II (IRINOTECAN) IN THE TREATMENT OF COLORECTAL-CANCER

      European journal of cancer
    14. MISSET JL; SALIBA F; GIACCHETTI S; BRAIN E; VASSAL G; BONNAY M; BASTIAN G; COTE C; MAHJOUBI M; HERAIT P; HAGIPANTELLI R; CVITKOVIC E
      PATHOPHYSIOLOGY AND THERAPY OF IRINOTECAN (CPT-11) INDUCED DELAYED-ONSET DIARRHEA (DD) - A PROSPECTIVE ASSESSMENT

      European journal of cancer
    15. CHABOT GG; ABIGERGES D; CATIMEL G; CULINE S; DEFORNI R; EXTRA JM; MAHJOUBI H; HERAIT P; ARMAND JP; BUGAT R; CLAVEL M; MARTY ME
      POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS OF IRINOTECAN (CPT-11) AND ACTIVE METABOLITE SN-38 DURING PHASE-I TRIALS

      Annals of oncology
    16. ABIGERGES D; CHABOT GG; ARMAND JP; HERAIT P; GOUYETTE A; GANDIA D
      PHASE-I AND PHARMACOLOGICAL STUDIES OF THE CAMPTOTHECIN ANALOG IRINOTECAN ADMINISTERED EVERY 3 WEEKS IN CANCER-PATIENTS

      Journal of clinical oncology
    17. MUNCK JN; ROUGIER P; CHABOT GG; RAMIREZ LH; BOGNEL C; LUMBROSO J; HERAIT P; ELIAS D; LASSER P; GOUYETTE A
      PHASE-I AND PHARMACOLOGICAL STUDY OF INTRAARTERIAL HEPATIC ADMINISTRATION OF PIRARUBICIN IN PATIENTS WITH ADVANCED HEPATIC METASTASES

      European journal of cancer
    18. MAHJOUBI M; ROUGIER P; OLIVIERA J; HERAIT P; TIGAUD JM; DROZ JP
      PHASE-II TRIAL OF PIRARUBICIN IN THE TREATMENT OF ADVANCED PANCREATIC-CANCER

      Cancer investigation
    19. ABIGERGES D; ARMAND JP; CHABOT GG; DACOSTA L; FADEL E; COTE C; HERAIT P; GANDIA D
      IRINOTECAN (CPT-11) HIGH-DOSE ESCALATION USING INTENSIVE HIGH-DOSE LOPERAMIDE TO CONTROL DIARRHEA

      Journal of the National Cancer Institute


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/01/21 alle ore 05:29:12